Phan Kim, Pamidi Sushmita, Gomez Yessica-Haydee, Gorgui Jessica, El-Messidi Amira, Gagnon Robert, Kimoff R John, Abenhaim Haim A, Daskalopoulou Stella S
Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Respiratory Division, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Am J Obstet Gynecol. 2022 Jun;226(6):833.e1-833.e20. doi: 10.1016/j.ajog.2021.11.1366. Epub 2021 Dec 2.
Impaired vascular function is a central feature of pathologic processes preceding the onset of preeclampsia. Arterial stiffness, a composite indicator of vascular health and an important vascular biomarker, has been found to be increased throughout pregnancy in those who develop preeclampsia and at the time of preeclampsia diagnosis. Although sleep-disordered breathing in pregnancy has been associated with increased risk for preeclampsia, it is unknown if sleep-disordered breathing is associated with elevated arterial stiffness in pregnancy.
This prospective observational cohort study aimed to evaluate arterial stiffness in pregnant women, with and without sleep-disordered breathing and assess the interaction between arterial stiffness, sleep-disordered breathing, and preeclampsia risk.
Women with high-risk singleton pregnancies were enrolled at 10 to 13 weeks' gestation and completed the Epworth Sleepiness Score, Pittsburgh Sleep Quality Index, and Restless Legs Syndrome questionnaires at each trimester. Sleep-disordered breathing was defined as loud snoring or witnessed apneas (≥3 times per week). Central arterial stiffness (carotid-femoral pulse wave velocity, the gold standard measure of arterial stiffness), peripheral arterial stiffness (carotid-radial pulse wave velocity), wave reflection (augmentation index, time to wave reflection), and hemodynamics (central blood pressures, pulse pressure amplification) were assessed noninvasively using applanation tonometry at recruitment and every 4 weeks from recruitment until delivery.
High-risk pregnant women (n=181) were included in the study. Women with sleep-disordered breathing (n=41; 23%) had increased carotid-femoral pulse wave velocity throughout gestation independent of blood pressure and body mass index (P=.042). Differences observed in other vascular measures were not maintained after adjustment for confounders. Excessive daytime sleepiness, defined by Epworth Sleepiness Score >10, was associated with increased carotid-femoral pulse wave velocity only in women with sleep-disordered breathing (P=.001). Midgestation (first or second trimester) sleep-disordered breathing was associated with an odds ratio of 3.4 (0.9-12.9) for preeclampsia, which increased to 5.7 (1.1-26.0) in women with sleep-disordered breathing and hypersomnolence, whereas late (third-trimester) sleep-disordered breathing was associated with an odds ratio of 8.2 (1.5-39.5) for preeclampsia.
High-risk pregnant women with midgestational sleep-disordered breathing had greater arterial stiffness throughout gestation than those without. Sleep-disordered breathing at any time during pregnancy was also associated with increased preeclampsia risk, and this effect was amplified by hypersomnolence.
血管功能受损是先兆子痫发作前病理过程的核心特征。动脉僵硬度是血管健康的综合指标和重要的血管生物标志物,已发现子痫前期患者在整个孕期及子痫前期诊断时动脉僵硬度均升高。虽然孕期睡眠呼吸障碍与子痫前期风险增加有关,但尚不清楚睡眠呼吸障碍是否与孕期动脉僵硬度升高有关。
这项前瞻性观察队列研究旨在评估有或无睡眠呼吸障碍的孕妇的动脉僵硬度,并评估动脉僵硬度、睡眠呼吸障碍和子痫前期风险之间的相互作用。
纳入妊娠10至13周的单胎高危孕妇,在每个孕期完成爱泼华嗜睡量表、匹兹堡睡眠质量指数和不安腿综合征问卷。睡眠呼吸障碍定义为大声打鼾或观察到呼吸暂停(每周≥3次)。采用压平式眼压计在入组时及从入组至分娩每4周进行一次无创评估中心动脉僵硬度(颈股脉搏波速度,动脉僵硬度的金标准测量指标)、外周动脉僵硬度(颈桡脉搏波速度)、波反射(增强指数、波反射时间)和血流动力学(中心血压、脉压放大)。
181名高危孕妇纳入研究。有睡眠呼吸障碍的孕妇(n = 41;23%)在整个孕期颈股脉搏波速度升高,独立于血压和体重指数(P = 0.042)。在调整混杂因素后,其他血管测量指标的差异未持续存在。爱泼华嗜睡量表评分>10定义为白天过度嗜睡,仅在有睡眠呼吸障碍的孕妇中与颈股脉搏波速度增加有关(P = 0.001)。孕中期(孕早期或孕中期)睡眠呼吸障碍与子痫前期的比值比为3.4(0.9 - 12.9),在有睡眠呼吸障碍和嗜睡的孕妇中增至5.7(1.1 - 26.0),而孕晚期(孕晚期)睡眠呼吸障碍与子痫前期的比值比为8.2(1.5 - 39.5)。
孕中期有睡眠呼吸障碍的高危孕妇在整个孕期的动脉僵硬度高于无睡眠呼吸障碍者。孕期任何时候的睡眠呼吸障碍也与子痫前期风险增加有关,且这种影响因嗜睡而放大。